Market Overview

Credit Suisse Reiterates Outperform on Mead Johnson Nutrition Following Management Meetings in China

Share:
Related MJN
Mead Johnson Dips Lower On Competitive Concerns In China
Goldman Shuffles Consumer Focus List: Cuts Mead Johnson, Adds Dollar Tree And TJX Cos.
Mead Johnson Nutrition (MJN) Peter Kasper Jakobsen on Q1 2016 Results - Earnings Call Transcript (Seeking Alpha)

In a report published Thursday, Credit Suisse analyst Robert Moskow reiterated an Outperform rating and $90.00 price target on Mead Johnson Nutrition Co. (NYSE: MJN).

In the report, Credit Suisse noted, “We recently attended meetings in China with Mead management. While the company is still struggling to get its arms around the volatility in the Chinese market, we continue to believe that there is some upside to consensus estimates owing to share gains from the temporary recall of competitors Danone and Abbott. This ‘gift' along with the easy comparisons to last year's missteps will give the stock some cover over the next two quarters while the Chinese market stabilizes.”

Mead Johnson Nutrition Co. closed on Wednesday at $74.25.

Latest Ratings for MJN

DateFirmActionFromTo
Apr 2016CitigroupMaintainsBuy
Mar 2016Credit SuisseUpgradesNeutralOutperform
Jan 2016Credit SuisseMaintainsNeutral

View More Analyst Ratings for MJN
View the Latest Analyst Ratings

Posted-In: Credit Suisse Robert MoskowAnalyst Color Reiteration Analyst Ratings

 

Related Articles (MJN)

View Comments and Join the Discussion!